IMNM icon

Immunome

30 hedge funds and large institutions have $9.34M invested in Immunome in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

less ownership

Funds ownership:

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

70% less call options, than puts

Call options by funds: $49K | Put options by funds: $163K

Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$49K
Puts
$163K
Net Calls
Net Calls Change

Top Buyers

1 +$747K
2 +$83K
3 +$77K
4
Renaissance Technologies
Renaissance Technologies
New York
+$38.9K
5
Group One Trading
Group One Trading
Illinois
+$27.6K

Top Sellers

1 -$1.76M
2 -$331K
3 -$47.5K
4
N
Natixis
France
-$39.9K
5
TRCT
Tower Research Capital (TRC)
New York
-$5.43K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.16M
2
$1.87M
3
$1.83M
4
$747K
5
$524K
6
$405K
7
$266K
8
$207K
9
$148K
10
$144K
11
$139K
12
$129K
13
$127K
14
$108K
15
$83.8K
16
$83K
17
$77K
18
$62.6K
19
$60.5K
20
$55.4K
21
$38.4K
22
$32K
23
$15K
24
$14.7K
25
$11.8K